Sheng Jiang

ORCID

Publication Activity (10 Years)

Years Active: 2018-2024
Publications (10 Years): 27

Top Venues

Journal of medicinal chemistry

Future medicinal chemistry

Angewandte Chemie (International ed. in English)

RSC advances

Shanghai Institute of Organic Chemistry (PHD)

This page only lists publications with an associated author ORCID identifier.

Education History

Shanghai Institute of Organic Chemistry Sep 01 2000 - Jul 01 2003

China

PHD

Publications

Lixin Zhou, Jiamei Yang, Kuojun Zhang, Tianyu Wang, Sheng Jiang, Xiangyu Zhang
Rising Star in Immunotherapy: Development and Therapeutic Potential of Small-Molecule Inhibitors Targeting Casitas B Cell Lymphoma-b (Cbl-b). Journal of medicinal chemistry 67 (2) (2024)
Lixin Zhou, Jiamei Yang, Kuojun Zhang, Tianyu Wang, Sheng Jiang, Xiangyu Zhang
Rising Star in Immunotherapy: Development and Therapeutic Potential of Small-Molecule Inhibitors Targeting Casitas B Cell Lymphoma-b (Cbl-b). Journal of medicinal chemistry 67 (2) (2024)
Lixin Zhou, Jiamei Yang, Kuojun Zhang, Tianyu Wang, Sheng Jiang, Xiangyu Zhang
Rising Star in Immunotherapy: Development and Therapeutic Potential of Small-Molecule Inhibitors Targeting Casitas B Cell Lymphoma-b (Cbl-b). Journal of medicinal chemistry 67 (2) (2024)
Lixin Zhou, Jiamei Yang, Kuojun Zhang, Tianyu Wang, Sheng Jiang, Xiangyu Zhang
Rising Star in Immunotherapy: Development and Therapeutic Potential of Small-Molecule Inhibitors Targeting Casitas B Cell Lymphoma-b (Cbl-b). Journal of medicinal chemistry (2024)
Kaizhen Wang, Xiangyu Zhang, Yao Cheng, Zhihao Qi, Ke Ye, Kuojun Zhang, Sheng Jiang, Yi Liu, Yibei Xiao, Tianyu Wang
Discovery of Novel PD-L1 Inhibitors That Induce the Dimerization, Internalization, and Degradation of PD-L1 Based on the Fragment Coupling Strategy. Journal of medicinal chemistry 66 (24) (2023)
Kaizhen Wang, Ke Ye, Xiangyu Zhang, Tianyu Wang, Zhihao Qi, Youjun Wang, Sheng Jiang, Kuojun Zhang
Dual Nicotinamide Phosphoribosyltransferase (NAMPT) and Indoleamine 2,3-Dioxygenase 1 (IDO1) Inhibitors for the Treatment of Drug-Resistant Nonsmall-Cell Lung Cancer. Journal of medicinal chemistry (2023)
Kaizhen Wang, Xiangyu Zhang, Yao Cheng, Zhihao Qi, Ke Ye, Kuojun Zhang, Sheng Jiang, Yi Liu, Yibei Xiao, Tianyu Wang
Discovery of Novel PD-L1 Inhibitors That Induce the Dimerization, Internalization, and Degradation of PD-L1 Based on the Fragment Coupling Strategy. Journal of medicinal chemistry 66 (24) (2023)
Kaizhen Wang, Ke Ye, Xiangyu Zhang, Tianyu Wang, Zhihao Qi, Youjun Wang, Sheng Jiang, Kuojun Zhang
Dual Nicotinamide Phosphoribosyltransferase (NAMPT) and Indoleamine 2,3-Dioxygenase 1 (IDO1) Inhibitors for the Treatment of Drug-Resistant Nonsmall-Cell Lung Cancer. Journal of medicinal chemistry 66 (1) (2023)
Kuojun Zhang, Ke Ye, He Tang, Zhihao Qi, Tianyu Wang, Jie Mao, Xiangyu Zhang, Sheng Jiang
Development and Therapeutic Implications of Tyrosine Kinase 2 Inhibitors. Journal of medicinal chemistry (2023)
Kaizhen Wang, Ke Ye, Xiangyu Zhang, Tianyu Wang, Zhihao Qi, Youjun Wang, Sheng Jiang, Kuojun Zhang
Dual Nicotinamide Phosphoribosyltransferase (NAMPT) and Indoleamine 2,3-Dioxygenase 1 (IDO1) Inhibitors for the Treatment of Drug-Resistant Nonsmall-Cell Lung Cancer. Journal of medicinal chemistry 66 (1) (2023)
Tianyu Wang, Kaizhen Wang, Yu Zhang, Kuojun Zhang, Shi Cai, Sheng Jiang, Yibei Xiao, Xiangyu Zhang
Novel Benzimidazoles as Potent Small-Molecule Inhibitors and Degraders of V-Domain Ig Suppressor of T-Cell Activation (VISTA). Journal of medicinal chemistry (2023)
Kaizhen Wang, Ke Ye, Xiangyu Zhang, Tianyu Wang, Zhihao Qi, Youjun Wang, Sheng Jiang, Kuojun Zhang
Dual Nicotinamide Phosphoribosyltransferase (NAMPT) and Indoleamine 2,3-Dioxygenase 1 (IDO1) Inhibitors for the Treatment of Drug-Resistant Nonsmall-Cell Lung Cancer. Journal of medicinal chemistry 66 (1) (2023)
Kaizhen Wang, Xiangyu Zhang, Yao Cheng, Zhihao Qi, Ke Ye, Kuojun Zhang, Sheng Jiang, Yi Liu, Yibei Xiao, Tianyu Wang
Discovery of Novel PD-L1 Inhibitors That Induce the Dimerization, Internalization, and Degradation of PD-L1 Based on the Fragment Coupling Strategy. Journal of medicinal chemistry 66 (24) (2023)
Kaizhen Wang, Xiangyu Zhang, Yao Cheng, Zhihao Qi, Ke Ye, Kuojun Zhang, Sheng Jiang, Yi Liu, Yibei Xiao, Tianyu Wang
Discovery of Novel PD-L1 Inhibitors That Induce the Dimerization, Internalization, and Degradation of PD-L1 Based on the Fragment Coupling Strategy. Journal of medicinal chemistry (2023)
Lu Lu, Zhihao Qi, Tianyu Wang, Xiangyu Zhang, Kuojun Zhang, Kaizhen Wang, Yao Cheng, Yibei Xiao, Zheng Li, Sheng Jiang
Design, Synthesis, and Evaluation of PD-1/PD-L1 Antagonists Bearing a Benzamide Scaffold. ACS medicinal chemistry letters 13 (4) (2022)
Kuojun Zhang, Kaizhen Wang, Xiangyu Zhang, Zhenlong Qian, Wenbo Zhang, Xiao Zheng, Jiaying Wang, Yin Jiang, Wanheng Zhang, Zhiyu Lu, Haiping Hao, Sheng Jiang
Discovery of Small Molecules Simultaneously Targeting NAD(P)H:Quinone Oxidoreductase 1 and Nicotinamide Phosphoribosyltransferase: Treatment of Drug-Resistant Non-small-Cell Lung Cancer. Journal of medicinal chemistry 65 (11) (2022)
Tianyu Wang, Shi Cai, Yao Cheng, Wanheng Zhang, Minmin Wang, Huiyong Sun, Binghua Guo, Zheng Li, Yibei Xiao, Sheng Jiang
Discovery of Small-Molecule Inhibitors of the PD-1/PD-L1 Axis That Promote PD-L1 Internalization and Degradation. Journal of medicinal chemistry 65 (5) (2022)
Shuai Zheng, Kuojun Zhang, Xiangyu Zhang, Yibei Xiao, Tianyu Wang, Sheng Jiang
Development of Inhibitors Targeting the V-Domain Ig Suppressor of T Cell Activation Signal Pathway. Journal of medicinal chemistry 65 (18) (2022)
Tianyu Wang, Shi Cai, Mingming Wang, Wanheng Zhang, Kuojun Zhang, Dong Chen, Zheng Li, Sheng Jiang
Novel Biphenyl Pyridines as Potent Small-Molecule Inhibitors Targeting the Programmed Cell Death-1/Programmed Cell Death-Ligand 1 Interaction. Journal of medicinal chemistry 64 (11) (2021)
Qi Miao, Wanheng Zhang, Kuojun Zhang, He Li, Jidong Zhu, Sheng Jiang
Rational design of a potent macrocyclic peptide inhibitor targeting the PD-1/PD-L1 protein-protein interaction. RSC advances 11 (38) (2021)
Kuojun Zhang, Zhiyi Liu, Yiwu Yao, Yatao Qiu, Feng Li, Dong Chen, Dale J Hamilton, Zheng Li, Sheng Jiang
Structure-Based Design of a Selective Class I Histone Deacetylase (HDAC) Near-Infrared (NIR) Probe for Epigenetic Regulation Detection in Triple-Negative Breast Cancer (TNBC). Journal of medicinal chemistry 64 (7) (2021)
Qicai Xiao, Huirong Lin, Juan Wu, Xin Pang, Quanming Zhou, Yue Jiang, Pan Wang, Wingnang Leung, Hungkay Lee, Sheng Jiang, Shao Q Yao, Liqian Gao, Gang Liu, Chuanshan Xu
Pyridine-Embedded Phenothiazinium Dyes as Lysosome-Targeted Photosensitizers for Highly Efficient Photodynamic Antitumor Therapy. Journal of medicinal chemistry 63 (9) (2020)
Minmin Wang, Tianyu Wang, Xiangyu Zhang, Xiaoxing Wu, Sheng Jiang
Cyclin-dependent kinase 7 inhibitors in cancer therapy. Future medicinal chemistry 12 (9) (2020)
Zhen Yang, Sheng Jiang, Feng Li, Yatao Qiu, Jianhua Gu, Roderic I Pettigrew, Mauro Ferrari, Dale J Hamilton, Zheng Li
Single-Molecule Force Measurement Guides the Design of Multivalent Ligands with Picomolar Affinity. Angewandte Chemie (International ed. in English) 58 (16) (2019)
Kuojun Zhang, Yiwu Yao, Zhengchao Tu, Chenzhong Liao, Zhen Wang, Yatao Qiu, Dong Chen, Dale J Hamilton, Zheng Li, Sheng Jiang
Discovery of class I histone deacetylase inhibitors based on romidpesin with promising selectivity for cancer cells. Future medicinal chemistry 12 (4) (2019)
Tianyu Wang, Xiaoxing Wu, Changying Guo, Kuojun Zhang, Jinyi Xu, Zheng Li, Sheng Jiang
Development of Inhibitors of the Programmed Cell Death-1/Programmed Cell Death-Ligand 1 Signaling Pathway. Journal of medicinal chemistry 62 (4) (2018)
Kuojun Zhang, Dong Chen, Kun Ma, Xiaoxing Wu, Haiping Hao, Sheng Jiang
NAD(P)H:Quinone Oxidoreductase 1 (NQO1) as a Therapeutic and Diagnostic Target in Cancer. Journal of medicinal chemistry 61 (16) (2018)

Sheng Jiang.css-eqlu8i{font-size:small;padding-left:4px;}

Publication Activity (10 Years)

Top Topics

Top Venues

Sheng Jiang